Intra-CA1 administration of FK-506 (tacrolimus) in rat impairs learning and memory in an inhibitory avoidance

Amirmasoud Hadjiasgary1, Hamid Reza Banafshe2, Abolfazl Ardjmand1

  • 1Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran.

Abstract

Insights

FK-506 (tacrolimus) impairs memory acquisition, consolidation, and retrieval in the hippocampus. This phosphatase inhibitor highlights calcineurin

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Calcineurin (CN) is a key phosphatase regulating learning, memory, and neural plasticity.
  • FK-506 (tacrolimus), a CN inhibitor, is an immunosuppressant with potential neurological effects.

Purpose of the Study:

  • To investigate the role of FK-506 in different memory stages using an inhibitory avoidance model.
  • To evaluate FK-506's impact on memory acquisition, consolidation, and retrieval in the hippocampus.

Main Methods:

  • Administered varying doses of FK-506 into the CA1 region of the hippocampus.
  • Tested FK-506's effects at different time points: before training, after training, and before testing.
  • Assessed memory using a step-through inhibitory avoidance paradigm, measuring latency to enter the dark compartment.

Main Results:

  • Pre-training FK-506 injections impaired inhibitory avoidance learning acquisition.
  • Post-training FK-506 injections impaired memory consolidation at 1, 2, and 3 hours post-training.
  • Pre-test FK-506 injections impaired memory retrieval.

Conclusions:

  • FK-506 selectively disrupts information processing (acquisition, retention, retrieval) in the hippocampal CA1.
  • Calcineurin's role in memory suggests FK-506 could be a therapeutic target for memory-related neurological conditions.

Related Concept Videos